| Mr Scott Christopher Murray, MED | |
|
590 Neff Ave, Suite 5000, Harrisonburg, VA 22801-3491 | |
| (540) 574-4327 | |
| Not Available |
| Full Name | Mr Scott Christopher Murray |
|---|---|
| Gender | Male |
| Speciality | Qualified Audiologist |
| Experience | 10 Years |
| Location | 590 Neff Ave, Harrisonburg, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841240892 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 2201000659 (Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Audiology Associates Of Harrisonburg, Llc | 6204832264 | 2 |
News Archive
The implantable cardioverter defibrillator (ICD) is a life saving battery operated device much like a pacemaker that is placed near the heart in a minor surgical procedure. This device detects abnormal heart rates and rhythms in the patient and delivers an electric shock to make the heart beat normally again. These save millions of people in the US and all over the world from sudden death.
...according to new brain imaging research at Wake Forest University Baptist Medical Center. Lowering participants' expectations about pain levels reduced both pain-related brain activity and how much pain they felt.
Arena Pharmaceuticals, Inc. today announced that Eisai Inc. will market lorcaserin for obesity and weight management in the United States following U.S. Food and Drug Administration (FDA) approval under the terms of a marketing and supply agreement between Arena Pharmaceuticals GmbH, a wholly owned subsidiary of Arena Pharmaceuticals, Inc., and Eisai. Lorcaserin, which Arena discovered and has developed for weight management, is intended for obese patients as well as overweight patients who have at least one weight-related co-morbid condition.
Practice makes perfect - or at least that's what we're told as we struggle through endless rounds of multiplication tables, goal kicks and piano scales - and it seems, based on the personal experience of many, to be true.
The AIDS Clinical Trials Group, the largest global HIV research network, today announced the launch of A5386, a phase 1 HIV cure study evaluating two promising therapies.
› Verified 8 days ago
| Provider Name | Audiology Associates Of Harrisonburg, Llc |
|---|---|
| Provider Type | Part B Supplier - Hospital Department(s) |
| Provider Identifiers | NPI Number: 1134142136 PECOS PAC ID: 6204832264 Enrollment ID: O20061013000546 |
News Archive
The implantable cardioverter defibrillator (ICD) is a life saving battery operated device much like a pacemaker that is placed near the heart in a minor surgical procedure. This device detects abnormal heart rates and rhythms in the patient and delivers an electric shock to make the heart beat normally again. These save millions of people in the US and all over the world from sudden death.
...according to new brain imaging research at Wake Forest University Baptist Medical Center. Lowering participants' expectations about pain levels reduced both pain-related brain activity and how much pain they felt.
Arena Pharmaceuticals, Inc. today announced that Eisai Inc. will market lorcaserin for obesity and weight management in the United States following U.S. Food and Drug Administration (FDA) approval under the terms of a marketing and supply agreement between Arena Pharmaceuticals GmbH, a wholly owned subsidiary of Arena Pharmaceuticals, Inc., and Eisai. Lorcaserin, which Arena discovered and has developed for weight management, is intended for obese patients as well as overweight patients who have at least one weight-related co-morbid condition.
Practice makes perfect - or at least that's what we're told as we struggle through endless rounds of multiplication tables, goal kicks and piano scales - and it seems, based on the personal experience of many, to be true.
The AIDS Clinical Trials Group, the largest global HIV research network, today announced the launch of A5386, a phase 1 HIV cure study evaluating two promising therapies.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Scott Christopher Murray, MED 590 Neff Ave, Suite 5000, Harrisonburg, VA 22801-3491 Ph: (540) 574-4327 | Mr Scott Christopher Murray, MED 590 Neff Ave, Suite 5000, Harrisonburg, VA 22801-3491 Ph: (540) 574-4327 |
News Archive
The implantable cardioverter defibrillator (ICD) is a life saving battery operated device much like a pacemaker that is placed near the heart in a minor surgical procedure. This device detects abnormal heart rates and rhythms in the patient and delivers an electric shock to make the heart beat normally again. These save millions of people in the US and all over the world from sudden death.
...according to new brain imaging research at Wake Forest University Baptist Medical Center. Lowering participants' expectations about pain levels reduced both pain-related brain activity and how much pain they felt.
Arena Pharmaceuticals, Inc. today announced that Eisai Inc. will market lorcaserin for obesity and weight management in the United States following U.S. Food and Drug Administration (FDA) approval under the terms of a marketing and supply agreement between Arena Pharmaceuticals GmbH, a wholly owned subsidiary of Arena Pharmaceuticals, Inc., and Eisai. Lorcaserin, which Arena discovered and has developed for weight management, is intended for obese patients as well as overweight patients who have at least one weight-related co-morbid condition.
Practice makes perfect - or at least that's what we're told as we struggle through endless rounds of multiplication tables, goal kicks and piano scales - and it seems, based on the personal experience of many, to be true.
The AIDS Clinical Trials Group, the largest global HIV research network, today announced the launch of A5386, a phase 1 HIV cure study evaluating two promising therapies.
› Verified 8 days ago
Mrs. Kristin Marie Quesenberry, MS Audiologist Medicare: Accepting Medicare Assignments Practice Location: 243 A Neff Avenue, Harrisonburg, VA 22801 Phone: 540-432-0071 Fax: 540-432-6079 | |
James Madison University Audiology Clinic Audiologist Medicare: Medicare Enrolled Practice Location: 235 Martin Luther King Jr. Way, Msc 4304, Harrisonburg, VA 22807 Phone: 540-568-6491 Fax: 540-568-5757 | |
Mr. Robert Reese Hinkle, PH.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 339 Lucy Dr, Harrisonburg, VA 22801 Phone: 540-434-3977 Fax: 540-433-7595 | |
Mrs. Kristin Jennifer Pinnow, PH D Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2062 Pro Pointe Ln, Harrisonburg, VA 22801 Phone: 540-434-2255 Fax: 540-434-8778 | |
Blue Ridge Hearing Center Inc Audiologist Medicare: Medicare Enrolled Practice Location: 243 A Neff Avenue, Harrisonburg, VA 22801 Phone: 540-432-0071 Fax: 540-432-6079 | |
Melissa Garber, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: Jmu Speech And Hearing Clinic, 235 Martin Luther Kind Way Msc 4304 Room 1120, Harrisonburg, VA 22807 Phone: 540-568-6491 |